Showing results (251-260 of 6,664) with videos related to

Sort By:
Pageof 667
Annals of Hematology|April 16, 2025
Prognostic role of interim PET-CT demonstrating partial metabolic response in diffuse large B-Cell lymphoma: a retrospective studyJinjie Gao, Shuozi Liu, Meixin Zhao, et al.
Annals of Hematology|April 15, 2025
Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6)Stephan Fuhrmann, Maike Nickelsen, Justin Hasenkamp, et al.
Annals of Hematology|April 15, 2025
Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised β-thalassemia major patients and exploring a potential correlation with von Willebrand factor and ADAMTS-13Anwar Al-Awadhi, Materah Salem Alwehaidah, Kefayah Al-Sabaan, et al.
Annals of Hematology|May 4, 2025
Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based studyWenshuai Zheng, Bo Peng, Huaxin Chen, et al.
Annals of Hematology|June 19, 2025
Efficacy and safety of rabbit ATLG and ATG in allogeneic hematopoietic stem cell transplantation for children with acquired severe aplastic anemiaSenlin Zhang, Qi Ji, Li Gao, et al.
Annals of Hematology|June 13, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective studyRonit Gurion, Dmitri Guz, Meirav Kedmi, et al.
Annals of Hematology|June 3, 2025
The outcomes of second haploidentical donor transplantation for graft failure in patients with severe aplastic anaemiaMing-Hao Lin, Ya-Jun Wang, Yuan-Yuan Zhang, et al.
Annals of Hematology|June 2, 2025
Three novel heterozygous ANK1 loss-of-function variants cause hereditary spherocytosis in Chinese familiesYang Wang, Tao Liu, Wen Wang, et al.
Annals of Hematology|June 3, 2025
Genomic mutation profile and metabolic alterations in diffuse large B-cell lymphoma with abdominal bulky massHan Zhang, Zijian Zhang, Liru Li, et al.
Annals of Hematology|June 5, 2025
Ixazomib-lenalidomid-dexamethasone (IRd) in relapsed refractory multiple myeloma (RRMM)-multicenter real-world analysis from Germany and comparative review of the literatureHanna Löffler, Magdalena Braun, Heike Reinhardt, et al.
Pageof 667